Rath ME - Search Results

1

Iron status in infants with alloimmune haemolytic disease in the first three months of life.

Rath ME, Smits-Wintjens VE, Oepkes D, Walther FJ, Lopriore E. Rath ME, et al. Vox Sang. 2013 Nov;105(4):328-33. doi: 10.1111/vox.12061. Epub 2013 Jun 27. Vox Sang. 2013. PMID: 23802744

2

Cerebral injury in twin-twin transfusion syndrome treated with fetoscopic laser surgery.

Spruijt M, Steggerda S, Rath M, van Zwet E, Oepkes D, Walther F, Lopriore E. Spruijt M, et al. Obstet Gynecol. 2012 Jul;120(1):15-20. doi: 10.1097/AOG.0b013e31825b9841. Obstet Gynecol. 2012. PMID: 22914388

3

Thrombocytopenia in neonates with polycythemia: incidence, risk factors and clinical outcome.

Vlug RD, Lopriore E, Janssen M, Middeldorp JM, Rath ME, Smits-Wintjens VE. Vlug RD, et al. Among authors: rath me. Expert Rev Hematol. 2015 Feb;8(1):123-9. doi: 10.1586/17474086.2015.997705. Epub 2014 Dec 30. Expert Rev Hematol. 2015. PMID: 25547250

4

Improving the management and outcome in haemolytic disease of the foetus and newborn.

Lopriore E, Rath ME, Liley H, Smits-Wintjens VE. Lopriore E, et al. Among authors: rath me. Blood Transfus. 2013 Oct;11(4):484-6. doi: 10.2450/2013.0147-13. Epub 2013 Jul 19. Blood Transfus. 2013. PMID: 24120585 Free PMC article. No abstract available.

5

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

Smits-Wintjens VE, Rath ME, van Zwet EW, Oepkes D, Brand A, Walther FJ, Lopriore E. Smits-Wintjens VE, et al. Among authors: rath me. Neonatology. 2013;103(2):141-7. doi: 10.1159/000343261. Epub 2012 Dec 11. Neonatology. 2013. PMID: 23235106

6

Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.

Rath ME, Smits-Wintjens VE, Lindenburg IT, Folman CC, Brand A, van Kamp IL, Oepkes D, Walther FJ, Lopriore E. Rath ME, et al. Transfusion. 2013 Jul;53(7):1580-5. doi: 10.1111/j.1537-2995.2012.03937.x. Epub 2012 Nov 1. Transfusion. 2013. PMID: 23113703

7

Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.

Smits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van Zwet EW, Walther FJ, Lopriore E. Smits-Wintjens VE, et al. Among authors: rath me. Neonatology. 2012;101(4):306-10. doi: 10.1159/000335333. Epub 2012 Feb 18. Neonatology. 2012. PMID: 22354012

8

Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.

Smits-Wintjens VE, Walther FJ, Rath ME, Lindenburg IT, te Pas AB, Kramer CM, Oepkes D, Brand A, Lopriore E. Smits-Wintjens VE, et al. Among authors: rath me. Pediatrics. 2011 Apr;127(4):680-6. doi: 10.1542/peds.2010-3242. Epub 2011 Mar 21. Pediatrics. 2011. PMID: 21422084 Clinical Trial.

9

Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.

Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E. Rath ME, et al. Early Hum Dev. 2011 Sep;87(9):583-8. doi: 10.1016/j.earlhumdev.2011.07.010. Epub 2011 Jul 27. Early Hum Dev. 2011. PMID: 21798676 Review.

10

Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease.

Rath ME, Smits-Wintjens VE, Oepkes D, van Zwet EW, van Kamp IL, Brand A, Walther FJ, Lopriore E. Rath ME, et al. Vox Sang. 2012 Apr;102(3):228-33. doi: 10.1111/j.1423-0410.2011.01539.x. Epub 2011 Sep 16. Vox Sang. 2012. PMID: 21923860 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results